Sertoli cell tumor and gonadoblastoma in an untreated 29-year-old 46,XY phenotypic male with Frasier syndrome carrying a WT1 IVS9+4C>T mutation.

Research output: Contribution to journalArticlepeer-review

  • External authors:
  • Sophia Kitsiou-Tzeli
  • Maria Deligiorgi
  • Sophia Malaktari-Skarantavou
  • Charalampos Vlachopoulos
  • Irene Fylaktou
  • Joanne Traeger-Synodinos
  • Christina Kanaka-Gantenbein
  • Christodoulos Stefanadis
  • Emmanuel Kanavakis

Abstract

OBJECTIVE: Frasier syndrome (FS) phenotype in 46,XY patients usually consists of female external genitalia, gonadal dysgenesis, high risk of gonadoblastoma and the development of end stage renal failure usually in the second decade of life. FS is caused by heterozygous de novo intronic splice site mutations of the Wilms' tumor suppressor gene 1 (WT1), although a few cases with typical exonic WT1 Denys-Drash mutations that resemble an FS phenotype have been described. The aim of this study was to present further data on the spectrum of FS phenotypes through the evaluation of a 29-year-old patient with a predominantly male phenotype and coexistence of Sertoli cell tumor and gonadoblastoma. RESULTS: Genetic analysis using standard methods for DNA sequencing confirmed FS due to a WT1 gene mutation, IVS9+4C>T. CONCLUSIONS: This very rare case illustrates the natural course of FS over many years due to the neglect by the patient to address his need for follow-up, while adding further data on the spectrum of FS phenotypes associated with IVS9+4 C>T mutations. The coexistence of the rare Sertoli cell tumor and gonadoblastoma emphasizes that early clinical recognition and molecular identification facilitates appropriate patient management, especially with respect to the high risk of gonadal malignancy.

Bibliographical metadata

Original languageEnglish
Pages (from-to)361-7
JournalHormones (Athens, Greece)
Volume11
Issue number3
Publication statusPublished - 2012